Mylan manufactures a tretinoin cream with a concentration of 0.025% [1]. Tretinoin is a topical retinoid used to treat acne and other skin conditions [2].
What is Mylan's tretinoin cream 0.025% used for?
Mylan's tretinoin cream 0.025% is primarily prescribed for the topical treatment of acne vulgaris [1][2]. It works by helping to unblock pores and reduce inflammation associated with acne [3].
How does tretinoin cream work?
Tretinoin is a derivative of vitamin A. Applied topically, it increases cell turnover and decreases the cohesiveness of the follicular epithelium, preventing the formation of new comedones and reducing existing ones [3]. It also has anti-inflammatory effects that can help with acne lesions [3].
What is the difference between tretinoin and other retinoids?
Tretinoin is a prescription-strength retinoid and is considered one of the most potent topical treatments available for acne [4]. Other retinoids, such as retinol, are available over-the-counter and are generally less potent and may take longer to show results [4].
When does Mylan's tretinoin cream patent expire?
Information regarding specific patent expiry dates for Mylan's tretinoin cream is available through patent databases. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity periods [5].
Can I buy Mylan tretinoin cream 0.025% over the counter?
Mylan's tretinoin cream 0.025% is a prescription medication. It requires a doctor's prescription to obtain [1][2].
What are the common side effects of tretinoin cream?
Common side effects of tretinoin cream include skin redness, peeling, dryness, and increased sensitivity to sunlight [2][3]. These effects are often temporary and tend to decrease as the skin adjusts to the medication [3].
How long does it take to see results with tretinoin cream?
It typically takes several weeks of consistent use to begin seeing improvements in acne with tretinoin cream. Full results may not be apparent for two to three months [3].
Sources:
1. https://www.drugpatentwatch.com/
2. [Source 1]
3. [Source 1]
4. [Source 1]
5. [Source 1]